Theriault RL - Search Results

1

Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.

Koh EH, Buzdar AU, Ames FC, Singletary SE, McNeese MD, Frye D, Holmes FA, Fraschini G, Hug V, Theriault RL, et al. Koh EH, et al. Among authors: theriault rl. Cancer Chemother Pharmacol. 1990;27(2):94-100. doi: 10.1007/BF00689090. Cancer Chemother Pharmacol. 1990. PMID: 2249339

2

Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer.

Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Dhingra K, et al. Clin Cancer Res. 1995 Jul;1(7):691-7. Clin Cancer Res. 1995. PMID: 9816034 Clinical Trial.

3

Feasibility of immediate breast reconstruction for locally advanced breast cancer.

Newman LA, Kuerer HM, Hunt KK, Ames FC, Ross MI, Theriault R, Fry N, Kroll SS, Robb GL, Singletary SE. Newman LA, et al. Ann Surg Oncol. 1999 Oct-Nov;6(7):671-5. doi: 10.1007/s10434-999-0671-6. Ann Surg Oncol. 1999. PMID: 10560853

4

Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.

Katz A, Strom EA, Buchholz TA, Thames HD, Smith CD, Jhingran A, Hortobagyi G, Buzdar AU, Theriault R, Singletary SE, McNeese MD. Katz A, et al. J Clin Oncol. 2000 Aug;18(15):2817-27. doi: 10.1200/JCO.2000.18.15.2817. J Clin Oncol. 2000. PMID: 10920129

5

Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.

Holmes FA, Walters RS, Theriault RL, Forman AD, Newton LK, Raber MN, Buzdar AU, Frye DK, Hortobagyi GN. Holmes FA, et al. Among authors: theriault rl. J Natl Cancer Inst. 1991 Dec 18;83(24):1797-805. doi: 10.1093/jnci/83.24.1797-a. J Natl Cancer Inst. 1991. PMID: 1683908 Clinical Trial.

6

Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.

Buzdar AU, Kau SW, Hortobagyi GN, Ames FC, Holmes FA, Fraschini G, Hug V, Theriault RL, McNeese MD, Singletary SE. Buzdar AU, et al. Among authors: theriault rl. Cancer. 1992 Jan 15;69(2):448-52. doi: 10.1002/1097-0142(19920115)69:2<448::aid-cncr2820690229>3.0.co;2-k. Cancer. 1992. PMID: 1728373

7

Phase I-II study of high-dose etoposide in patients with refractory breast cancer.

Fraschini G, Holmes FA, Esparza L, Theriault RL, Buzdar AU, Hortobagyi GN. Fraschini G, et al. Among authors: theriault rl. Invest New Drugs. 1991 Nov;9(4):365-7. doi: 10.1007/BF00183583. Invest New Drugs. 1991. PMID: 1804815 Clinical Trial. No abstract available.

8

Acute superior vena caval thrombosis after central venous catheter removal: successful treatment with thrombolytic therapy.

Theriault RL, Buzdar AU. Theriault RL, et al. Med Pediatr Oncol. 1990;18(1):77-80. doi: 10.1002/mpo.2950180117. Med Pediatr Oncol. 1990. PMID: 2152960

9

Pirarubicin in combination chemotherapy for metastatic breast cancer.

Hortobagyi GN, Theriault RL, Frye D, Walters RS, Fraschini G, Tashima CK, Ro JS, Salewski E, Buzdar AU. Hortobagyi GN, et al. Among authors: theriault rl. Am J Clin Oncol. 1990;13 Suppl 1:S54-6. doi: 10.1097/00000421-199012001-00012. Am J Clin Oncol. 1990. PMID: 2291460

10

The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.

Theriault RL, Hortobagyi GN, Fritsche HA, Frye D, Martinez R, Buzdar AU. Theriault RL, et al. Cancer. 1989 Mar 1;63(5):828-35. doi: 10.1002/1097-0142(19890301)63:5<828::aid-cncr2820630506>3.0.co;2-3. Cancer. 1989. PMID: 2914290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters